These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 26880220)

  • 1. The Total Incidence of Complications and the Impact of an Anticoagulation Regime on Adverse Events After Cryoballoon Ablation of Atrial Fibrillation: A Single-Center Study of 409 Patients.
    Koektuerk B; Turan CH; Yorgun H; Keskin K; Schoett M; Dahmen A; Gorr E; Yang A; Hoppe C; Horlitz M; Turan RG
    Cardiovasc Ther; 2016 Jun; 34(3):144-51. PubMed ID: 26880220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apixaban, rivaroxaban, and dabigatran use in patients undergoing catheter ablation for atrial fibrillation using the second-generation cryoballoon.
    Tscholl V; Lsharaf AK; Lin T; Bellmann B; Nagel P; Lenz K; Landmesser U; Roser M; Rillig A
    Clin Cardiol; 2017 Nov; 40(11):1095-1099. PubMed ID: 28846806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants.
    Mugnai G; de Asmundis C; Iacopino S; Stroker E; Longobardi M; De Regibus V; Coutino-Moreno HE; Takarada K; Choudhury R; Abugattas de Torres JP; Storti C; Brugada P; Chierchia GB
    Am J Cardiol; 2017 Jul; 120(2):223-229. PubMed ID: 28532773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.
    Okishige K; Nakamura T; Aoyagi H; Kawaguchi N; Yamashita M; Kurabayashi M; Suzuki H; Asano M; Shimura T; Yamauchi Y; Sasano T; Hirao K
    J Cardiol; 2017 Jan; 69(1):11-15. PubMed ID: 27160710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of novel oral anticoagulants in catheter ablation of atrial fibrillation.
    Hansen PS; Sanchez R; Walfridsson H
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
    Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S
    Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How safe are NOACs compared with phenprocoumon after pulmonary vein isolation with the cryoballoon technique using purse-string suture closure?
    Akkaya E; Berkowitsch A; Zaltsberg S; Deubner N; Greiss H; Hain A; Hamm CW; Sperzel J; Kuniss M; Neumann T
    Int J Cardiol; 2017 Dec; 248():201-207. PubMed ID: 28688719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

  • 10. Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients.
    Bluecher A; Meyer Dos Santos S; Ferreirós N; Labocha S; Meyer Dos Santos IM; Picard-Willems B; Harder S; Singer OC
    Thromb Haemost; 2017 Feb; 117(3):519-528. PubMed ID: 28124061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation.
    Hohnloser SH; Basic E; Hohmann C; Nabauer M
    Thromb Haemost; 2018 Mar; 118(3):526-538. PubMed ID: 29359278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-year clinical success of a 'no-bonus' freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation.
    Wissner E; Heeger CH; Grahn H; Reissmann B; Wohlmuth P; Lemes C; Rausch P; Mathew S; Rillig A; Deiss S; Maurer T; Lin T; Tilz RR; Ouyang F; Kuck KH; Metzner A
    Europace; 2015 Aug; 17(8):1236-40. PubMed ID: 25868468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single 3-minute freeze for second-generation cryoballoon ablation: one-year follow-up after pulmonary vein isolation.
    Ciconte G; de Asmundis C; Sieira J; Conte G; Di Giovanni G; Mugnai G; Saitoh Y; Baltogiannis G; Irfan G; Coutiño-Moreno HE; Hunuk B; Velagić V; Brugada P; Chierchia GB
    Heart Rhythm; 2015 Apr; 12(4):673-80. PubMed ID: 25542427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bonus-freeze: benefit or risk? Two-year outcome and procedural comparison of a "bonus-freeze" and "no bonus-freeze" protocol using the second-generation cryoballoon for pulmonary vein isolation.
    Heeger CH; Wissner E; Wohlmuth P; Mathew S; Hayashi K; Sohns C; Reißmann B; Lemes C; Maurer T; Saguner AM; Santoro F; Riedl J; Ouyang F; Kuck KH; Metzner A
    Clin Res Cardiol; 2016 Sep; 105(9):774-82. PubMed ID: 27085722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends and Characteristics of Emergency Department Patients Prescribed Novel Oral Anticoagulants.
    Ganetsky M
    J Emerg Med; 2015 Nov; 49(5):693-7. PubMed ID: 26149803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year follow-up after second-generation cryoballoon ablation for atrial fibrillation in a large cohort of patients: a single-centre experience.
    Irfan G; de Asmundis C; Mugnai G; Poelaert J; Verborgh C; Umbrain V; Beckers S; Hacioglu E; Hunuk B; Velagic V; Stroker E; Brugada P; Chierchia GB
    Europace; 2016 Jul; 18(7):987-93. PubMed ID: 26705562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.
    Kanai Y; Oguro H; Tahara N; Matsuda H; Takayoshi H; Mitaki S; Onoda K; Yamaguchi S
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):338-345. PubMed ID: 29033229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shortening of freezing cycles provides equal outcome to standard ablation procedure using second-generation 28 mm cryoballoon after 15-month follow-up.
    Tebbenjohanns J; Höfer C; Bergmann L; Dedroogh M; Gaudin D; von Werder A; Rühmkorf K
    Europace; 2016 Feb; 18(2):206-10. PubMed ID: 26071236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.
    Li PJ; Xiao J; Yang Q; Feng Y; Wang T; Liu GJ; Liang ZA
    J Interv Card Electrophysiol; 2016 Sep; 46(3):213-24. PubMed ID: 27001171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between asymptomatic gastroesophageal excessive transmural injury after pulmonary vein isolation and a bonus freeze protocol using the second-generation 28-mm cryoballoon for paroxysmal atrial fibrillation.
    Yoshiga Y; Okamoto T; Shimizu A; Ueyama T; Ono M; Mito T; Fukuda M; Ishiguchi H; Omuro T; Kobayashi S; Goto A; Nishikawa J; Sakaida I; Yano M
    J Cardiol; 2019 Dec; 74(6):494-500. PubMed ID: 31255462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.